QR код

PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs

BackgroundsEpidermal growth factor receptor (EGFR) mutation profiles play a vital role in treatment strategy decisions for non–small cell lung cancer (NSCLC). The purpose of this study was to evaluate the predictive efficacy of baseline 18F-FDG PET/CT-based radiomics analysis for EGFR mutation statu...

Повний опис

Збережено в:
Автори: Liping Yang, Panpan Xu, Mengyue Li, Menglu Wang, Mengye Peng, Ying Zhang, Tingting Wu, Wenjie Chu, Kezheng Wang, Hongxue Meng, Lingbo Zhang
Формат: Artigo
Мова:Inglês
Опубліковано: Frontiers Media S.A. 2022-06-01
Серія:Frontiers in Oncology
Предмети:
non-small cell lung cancer
PET-CT
radiomics
nomogram
EGFR mutation
survival prognosis
Онлайн доступ:https://www.frontiersin.org/articles/10.3389/fonc.2022.894323/full
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси